IREN Budgets $25 Billion To $30 Billion For Its AI Build-Out — More Than Its Entire $13.9 Billion Market Value
IREN stock has plunged 54% from highs earlier this year.
Latest
Arista CEO Jayshree Ullal's Trusts Sold $21.1 Million Of Stock Under A Plan Set In November 2025
A Form 4 shows three trust accounts sold 96,992 shares on Wednesday, the fourth sale in her five latest filings.
Bambusa Files For Nasdaq IPO With $41.1 Million Loss, No Revenue And A Going-Concern Warning
The Boston antibody developer's S-1 leaves price and share count blank and says $71.5 million in cash may not last a year.
Standard BioTools Holders Would Own About 16% Of Treeline Combination, Amended S-4 Shows
The second amended filing sets an exchange ratio range, a 12-seat board and a $2.5 billion Treeline value against $460 million for Standard BioTools.
EU Names Eldorado Gold's Skouries Mine A Strategic Project, Backing A $2 Billion-Plus Greek Copper Build
The European Commission picked the Greek copper-gold mine under its Critical Raw Materials Act, the company said in a statement.
AutoZone Director Claire McDonough Will Leave The Board In 2026 Over A Calendar Clash, Not A Dispute
McDonough told AutoZone's board she will not stand for reelection after taking a new executive job whose calendar conflicts with board meetings.
Integra Prices $450 Million Of 9.500% Notes, Expects Rate Increase Near High End Of 100-200 Basis Point Range
The refinancing is expected to raise Integra's effective interest rate near the top of the range management flagged earlier.
Sidus Space Audit Chair And Another Director Resign Same Day, And The Company Disputes Both Letters
An 8-K shows Tiffany Norwood and Kelle Wendling left the board Tuesday; Sidus Space says it disagrees with their letters.
Live Nation Prices $730 Million And €600 Million Of Notes To Pay Off 6.500% Debt
Live Nation says swaps on its dollar notes put the blended rate at about 5.89%, against 6.500% on the 2027 notes it will redeem.
Crescent Energy Prices 80 Million Shares At $12.50 To Help Fund Devon Eagle Ford Purchase
A KKR-affiliated holder agreed to buy 40 million shares, and underwriters took up their full 12 million-share option on Friday.
Fairmount-Linked Holders Of 9.99% Of Spyre Therapeutics Agree To 60-Day Lock-Up After Offering
Amendment No. 8 to a Schedule 13D reports the lock-up only; the holders did not buy shares and their position is unchanged since June.
Dolan Reports 100 MSGS Spinco Shares, All Held Indirectly, As Spinoff Registration Takes Effect
James Dolan's Form 3 lists 100 shares held through Madison Square Garden Sports and its subsidiaries, and he disclaims ownership.
Deals
Calix Board Adds $100 Million To Buyback Authorization, With No Commitment To Buy
An 8-K says the extra $100 million obliges Calix to buy no stock, and the program can be paused or ended at any time.
Deals
Viatris Agrees To Buy Pacira For $36.50 A Share In Cash, A $1.65 Billion Deal With A $62.0 Million Break Fee
The tender offer for the maker of Exparel and Zilretta must launch within 15 business days, with a close targeted by the end of 2026.
Deals
Viatris Agrees To Buy Pacira For $36.50 A Share, A $1.65 Billion Bet On Non-Opioid Pain Drugs
The all-cash tender offer adds Exparel and Zilretta, with a $62 million termination fee payable by Pacira in specified cases.
Deals
Copart Pushes ACV Auctions Tender Deadline To October 15 After 52.84% Of Shares Tendered
The $10.50-a-share cash offer is unchanged, and Amendment No. 3 to the Schedule TO moves the expiration out eight days.
Deals
Medtronic's MiniMed Exchange Ratio Lands At The 4.5939 Cap, With The Offer Expiring At Midnight Friday
Medtronic's calculated values would have produced a ratio above the upper limit, so the offer's terms were set at the cap.
Deals
Atrium Therapeutics Agrees To Sell About $50 Million Of Stock At $7.93, Says Cash Now Lasts Through 2028
The 8-K describes a private placement with Casdin, Aberdeen and others, plus pre-funded warrants and a 50-day deadline for a resale filing.
Deals
Centinel Spine Files For NYSE Listing With $10.2 Million First-Half Profit, But Offering Terms Are Blank
The spine-implant company's S-1 shows 42% sales growth for six months, a $136.1 million debt load and a tax payment deal for existing owners.
Deals
Neogen's 10-Q Drops Its Closing Target For The Zoetis Genomics Sale; Two Regulators Now Run To December
Australian and New Zealand reviews of the Genomics divestiture are both in a second phase, with the company expecting them to end by December's close.
Deals
Golar LNG Agrees To Buy 2013-Built Carrier For Fourth FLNG Unit, Targets 2029 Redelivery
The release gives no price for the Grace Dahlia, which Golar plans to convert in China alongside FLNG Esperanza.
Deals
Ultragenyx Agrees To Sell FDA Priority Review Voucher For $210 Million Cash, 8-K Says
The drugmaker owes the NIH 20% of gross proceeds, and the sale still needs antitrust waiting-period clearance before it closes.
Deals
Sportradar Will Sell Its Atrium Sports Coaching Unit To Teamworks For $170 Million In Cash
The Swiss sports-data company plans to keep several technology assets already built into its core products, and expects to close in the fourth quarter.
Deals
Worthington Steel Posts $7.0 Million Quarterly Loss As Kloeckner Deal Costs Outweigh Tripled Sales
Sales rose 212% to $2,726.6 million with Kloeckner included, but acquisition expenses and fair-value charges produced a net loss versus a year-ago profit.